Literature DB >> 24802804

Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma.

Katsuhiro Hanada1, David Y Graham.   

Abstract

Gastric carcinoma is an inflammation-related cancer caused by long-term infection with the human bacterial pathogen, Helicobacter pylori. The pattern of acute-on-chronic inflammation causes progressive mucosal damage which may result in atrophy with metaplastic epithelia and eventually gastric cancer. Recently, it has been recognized that H. pylori can also cause genetic instability such as double-stranded DNA breaks and can produce gene activation and silencing via epigenetic pathways. As genetic instability is the hallmark of cancer, we highlight recent progress in understanding the gastric carcinogenesis in relation to H. pylori-related inflammation, H. pylori-induced double-stranded DNA breakage and aberrant gene expression as well as the mechanisms and role of H. pylori-associated epigenetic change in gene expression.

Entities:  

Keywords:  DNA breakage; Helicobacter pylori; epigenetic gene expression changes; food intake; genome instabilities; inflammations; intestinal-type gastric cancers; virulence factors

Mesh:

Year:  2014        PMID: 24802804     DOI: 10.1586/14737140.2014.911092

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  19 in total

1.  Changing the natural history of metachronous gastric cancer after H. pylori eradication.

Authors:  David Y Graham; Satoko Matsueda; Akiko Shiotani
Journal:  Jpn J Helicobacter Res       Date:  2015

2.  RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.

Authors:  David Y Graham; Masahiro Asaka
Journal:  J Natl Cancer Inst       Date:  2014-11-07       Impact factor: 13.506

3.  Inhibition of polarity-regulating kinase PAR1b contributes to Helicobacter pylori inflicted DNA Double Strand Breaks in gastric cells.

Authors:  Andrea Zamperone; David Cohen; Markus Stein; Charlotte Viard; Anne Müsch
Journal:  Cell Cycle       Date:  2019-01-13       Impact factor: 4.534

Review 4.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

Review 5.  Identifying the pre-malignant stomach: from guidelines to practice.

Authors:  Jonathan R White; Matthew Banks
Journal:  Transl Gastroenterol Hepatol       Date:  2022-01-25

6.  Prostate stem cell antigen gene TT genotype and development of intestinal metaplasia in Helicobacter pylori infection.

Authors:  Takahiro Uotani; Mitsushige Sugimoto; Hitomi Ichikawa; Shingo Tanaka; Hiroyuki Nagashima; Tomohisa Uchida; David Y Graham; Yoshio Yamaoka
Journal:  J Dig Dis       Date:  2016-01       Impact factor: 2.325

Review 7.  An Update on Helicobacter pylori as the Cause of Gastric Cancer.

Authors:  Wei Zhang; Hong Lu; David Y Graham
Journal:  Gastrointest Tumors       Date:  2014-07-18

8.  H. pylori infection alters repair of DNA double-strand breaks via SNHG17.

Authors:  Taotao Han; Xiaohui Jing; Jiayu Bao; Lianmei Zhao; Aidong Zhang; Renling Miao; Hui Guo; Baoguo Zhou; Shang Zhang; Jiazeng Sun; Juan Shi
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 9.  Chemoprevention Against Gastric Cancer.

Authors:  Shailja C Shah; Richard M Peek
Journal:  Gastrointest Endosc Clin N Am       Date:  2021-07

Review 10.  Microbiome and Gastric Cancer.

Authors:  Lars Engstrand; David Y Graham
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.